LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 175 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 1.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,862,652 | +10.7% | 22,106 | -4.0% | 0.00% | 0.0% |
Q1 2024 | $1,682,689 | +9.3% | 23,019 | +6.8% | 0.00% | 0.0% |
Q4 2023 | $1,539,744 | +19.1% | 21,559 | -0.1% | 0.00% | 0.0% |
Q3 2023 | $1,293,014 | -16.9% | 21,579 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $1,555,846 | -11.5% | 21,579 | -9.7% | 0.00% | 0.0% |
Q1 2023 | $1,757,348 | +3.9% | 23,890 | -5.7% | 0.00% | 0.0% |
Q4 2022 | $1,691,643 | -22.4% | 25,324 | +0.1% | 0.00% | 0.0% |
Q3 2022 | $2,179,000 | -3.9% | 25,308 | -0.4% | 0.00% | 0.0% |
Q2 2022 | $2,267,000 | -20.5% | 25,407 | +0.2% | 0.00% | 0.0% |
Q1 2022 | $2,853,000 | -26.8% | 25,363 | +0.5% | 0.00% | 0.0% |
Q4 2021 | $3,898,000 | +1.6% | 25,239 | -8.3% | 0.00% | -50.0% |
Q3 2021 | $3,836,000 | -30.2% | 27,534 | -34.3% | 0.00% | 0.0% |
Q2 2021 | $5,497,000 | -19.6% | 41,902 | -6.6% | 0.00% | -33.3% |
Q1 2021 | $6,839,000 | +56.1% | 44,862 | +1.9% | 0.00% | +50.0% |
Q4 2020 | $4,380,000 | -24.2% | 44,045 | -27.3% | 0.00% | -33.3% |
Q3 2020 | $5,777,000 | -23.2% | 60,608 | -9.9% | 0.00% | -25.0% |
Q2 2020 | $7,520,000 | +51.8% | 67,231 | -1.3% | 0.00% | 0.0% |
Q1 2020 | $4,955,000 | -30.0% | 68,141 | +0.4% | 0.00% | 0.0% |
Q4 2019 | $7,077,000 | +2.2% | 67,861 | -2.5% | 0.00% | 0.0% |
Q3 2019 | $6,927,000 | -14.3% | 69,591 | -1.7% | 0.00% | -20.0% |
Q2 2019 | $8,081,000 | -12.9% | 70,791 | -4.1% | 0.01% | -16.7% |
Q1 2019 | $9,283,000 | -3.7% | 73,841 | +4.0% | 0.01% | -14.3% |
Q4 2018 | $9,636,000 | -24.4% | 71,011 | +53.0% | 0.01% | -12.5% |
Q3 2018 | $12,739,000 | +31.6% | 46,409 | -0.6% | 0.01% | +14.3% |
Q2 2018 | $9,677,000 | +28.1% | 46,709 | +2.1% | 0.01% | +40.0% |
Q1 2018 | $7,554,000 | +19.8% | 45,739 | -0.7% | 0.01% | 0.0% |
Q4 2017 | $6,307,000 | +0.6% | 46,059 | 0.0% | 0.01% | 0.0% |
Q3 2017 | $6,271,000 | +12.1% | 46,059 | 0.0% | 0.01% | +25.0% |
Q2 2017 | $5,592,000 | +37.6% | 46,059 | +19.9% | 0.00% | +33.3% |
Q1 2017 | $4,064,000 | +23.4% | 38,399 | +18.5% | 0.00% | 0.0% |
Q4 2016 | $3,293,000 | -0.5% | 32,409 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $3,308,000 | -14.4% | 32,409 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $3,865,000 | +29.8% | 32,409 | +16.5% | 0.00% | 0.0% |
Q1 2016 | $2,978,000 | -11.4% | 27,809 | -10.3% | 0.00% | 0.0% |
Q4 2015 | $3,362,000 | +12.9% | 31,009 | -10.8% | 0.00% | 0.0% |
Q3 2015 | $2,977,000 | -23.9% | 34,759 | -10.4% | 0.00% | 0.0% |
Q2 2015 | $3,914,000 | +27.6% | 38,789 | -2.5% | 0.00% | +50.0% |
Q1 2015 | $3,068,000 | +44.9% | 39,789 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $2,117,000 | +13.2% | 39,789 | 0.0% | 0.00% | 0.0% |
Q3 2014 | $1,870,000 | -24.5% | 39,789 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $2,478,000 | -7.6% | 39,789 | -0.3% | 0.00% | 0.0% |
Q1 2014 | $2,683,000 | +50.5% | 39,894 | +17.7% | 0.00% | 0.0% |
Q4 2013 | $1,783,000 | +15.1% | 33,901 | -5.3% | 0.00% | 0.0% |
Q3 2013 | $1,549,000 | +8.6% | 35,795 | -6.1% | 0.00% | 0.0% |
Q2 2013 | $1,426,000 | – | 38,115 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
KNOTT DAVID M | 1,199,766 | $130,078,630,000 | 35.65% |
CARDINAL CAPITAL MANAGEMENT LLC /CT | 852,053 | $92,380,000 | 5.34% |
OBERWEIS ASSET MANAGEMENT INC/ | 101,127 | $10,964,000 | 3.08% |
Timpani Capital Management LLC | 68,160 | $7,390,000 | 3.00% |
ASHFORD CAPITAL MANAGEMENT INC | 103,420 | $11,213,000 | 2.64% |
First Light Asset Management, LLC | 56,818 | $6,160,000 | 2.58% |
Conestoga Capital Advisors, LLC | 286,162 | $31,026,000 | 2.51% |
OAK RIDGE INVESTMENTS LLC | 955,599 | $103,606,000 | 2.48% |
RK Capital | 127,983 | $13,876,000 | 2.42% |
Nichols Asset Management LLC | 93,170 | $10,101,000 | 2.20% |